Ossama K. Abou Hassan

Ossama K. Abou Hassan

Auto-generated profile, based on publicly available information

Ossama K. Abou Hassan

Department of Heart Failure and Transplant, Division of Cardiology, Baylor Scott and White Medical Center, Temple, TX, US

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 November 2019 in IEEE Journal of Translational Engineering in Health and Medicine
Verified
Journal Article
Open access
MBMohammed Baydoun
Mohammed Baydoun
LSLise Safatly
Lise Safatly
OHOssama K. Abou Hassan
Ossama K. Abou Hassan
HGHassan Ghaziri
Hassan Ghaziri
AHAli El Hajj
Ali El Hajj
HIHussain Isma'EEl
Hussain Isma'EEl
Introduction: The electrocardiogram (ECG) plays an important role in the diagnosis of heart diseases. However, most patterns of diseases are based on old datasets and stepwise algorithms that provide limited accuracy. Improving diagnostic accuracy of the ECG can be done by applying machine learning algorithms. This requires taking existing scanned or printed ECGs of old cohorts and transforming the ECG signal to the raw digital (time (milliseconds), voltage (millivolts)) form. Objectives: We present a MATLAB-based tool and algorithm that converts a printed or scanned format of the ECG into a digitized ECG signal. Methods: 30 ECG scanned curves are utilized in our study. An image processing method is first implemented for detecting the ECG regions of interest and extracting the ECG signals. It is followed by serial steps that digitize and validate the results. Results: The validation demonstrates very high correlation values of several standard ECG parameters: PR interval 0.984 +/-0.021 (p-value < 0.001), QRS interval 1+/-SD (p-value < 0.001), QT interval 0.981 +/-0.023 p-value <0.001, and RR interval 1 +/-0.001 p-value <0.001. Conclusion: Digitized ECG signals from existing paper or scanned ECGs can be obtained with more than 95% of precision. This makes it possible to utilize historic ECG signals in machine learning algorithms to identify patterns of heart diseases and aid in the diagnostic and prognostic evaluation of patients with cardiovascular disease.

1 October 2020 in Circulation: Genomic and Precision Medicine
Verified
Journal Article
Open access
PDF file
AFAkl C. Fahed
Akl C. Fahed
Georges NemerGeorges Nemer
Georges Nemer
FBFadi F Bitar
Fadi F Bitar
SASamir Arnaout
Samir Arnaout
AAAntoine B. Abchee
Antoine B. Abchee
CSChristine Seidman
Christine Seidman
Background: Cardiac troponin I ( TNNI3 ) gene mutations account for 3% of hypertrophic cardiomyopathy and carriers have a heterogeneous phenotype, with increased risk of sudden cardiac death (SCD). Only one mutation (p.Arg21Cys) has been reported in the N terminus of the protein. In model organisms, it impairs PKA (protein kinase A) phosphorylation, increases calcium sensitivity, and causes diastolic dysfunction. The phenotype of this unique mutation in patients with hypertrophic cardiomyopathy remains unknown. Methods: We sequenced 29 families with hypertrophic cardiomyopathy enriched for pediatric-onset disease and identified 5 families with the TNNI3 p.Arg21Cys mutation. Using cascade screening, we studied the clinical phenotype of 57 individuals from the 5 families with TNNI3 p.Arg21Cys-related cardiomyopathy. We performed survival analysis investigating the age at first SCD in carriers of the mutation. Results: All 5 families with TNNI3 p.Arg21Cys were from South Lebanon. TNNI3 p.Arg21Cys-related cardiomyopathy manifested a malignant phenotype—SCD occurred in 30 (53%) of 57 affected individuals at a median age of 22.5 years. In select carriers without left ventricular hypertrophy on echocardiogram, SCD occurred, myocyte disarray was found on autopsy heart, and tissue Doppler and cardiac magnetic resonance imaging identified subclinical disease features such as diastolic dysfunction and late gadolinium enhancement. Conclusions: The TNNI3 p.Arg21Cys mutation has a founder effect in South Lebanon and causes malignant hypertrophic cardiomyopathy with early SCD even in the absence of hypertrophy. Genetic diagnosis with this mutation may be sufficient for risk stratification for SCD.

18 October 2019 in Scandinavian Cardiovascular Journal
Verified
Journal Article
Closed access
JWJason Leo Walsh
Jason Leo Walsh
WAWael A. AlJaroudi
Wael A. AlJaroudi
NLNader Lamaa
Nader Lamaa
OHOssama K. Abou Hassan
Ossama K. Abou Hassan
KJKhalil Jalkh
Khalil Jalkh
HIHussain Isma’eEl
Hussain Isma’eEl
Objectives. In heart failure, invasive angiography is often employed to differentiate ischaemic from non-ischaemic cardiomyopathy. We aim to examine the predictive value of echocardiographic strain features alone and in combination with other features to differentiate ischaemic from non-ischaemic cardiomyopathy, using artificial neural network (ANN) and logistic regression modelling. Design. We retrospectively identified 204 consecutive patients with an ejection fraction <50% and a diagnostic angiogram. Patients were categorized as either ischaemic (n = 146) or non-ischaemic cardiomyopathy (n = 58). For each patient, left ventricular strain parameters were obtained. Additionally, regional wall motion abnormality, 13 electrocardiographic (ECG) features and six demographic features were retrieved for analysis. The entire cohort was randomly divided into a derivation and a validation cohort. Using the parameters retrieved, logistic regression and ANN models were developed in the derivation cohort to differentiate ischaemic from non-ischaemic cardiomyopathy, the models were then tested in the validation cohort. Results. A final strain-based ANN model, full feature ANN model and full feature logistic regression model were developed and validated, F1 scores were 0.82, 0.79 and 0.63, respectively. Conclusions. Both ANN models were more accurate at predicting cardiomyopathy type than the logistic regression model. The strain-based ANN model should be validated in other cohorts. This model or similar models could be used to aid the diagnosis of underlying heart failure aetiology in the form of the online calculator (https://cimti.usj.edu.lb/strain/index.html) or built into echocardiogram software.

21 June 2022 in Open Heart
Verified
Journal Article
Open access
PDF file
RNRaunak M Nair
Raunak M Nair
SCSanchit Chawla
Sanchit Chawla
BVBeni Verma
Beni Verma
SKSachin Kumar
Sachin Kumar
OHOssama Abou Hassan
Ossama Abou Hassan
SKSamir Kapadia
Samir Kapadia
Background Increase in left ventricular filling pressure (FP) and diastolic dysfunction are established consequences of progressive aortic stenosis (AS). However, the impact of elevated FP as detected by pretranscatheter aortic valve replacement (TAVR) echocardiogram on long-term outcomes after TAVR remains unclear. Objective To understand the impact of elevated FP in patients with severe AS who undergo TAVR. Methods This was a retrospective study of all patients who underwent TAVR between 1 January 2014 and 31 December 2017. The presence of elevated FP was determined in accordance with the latest guidelines using the last available comprehensive echocardiogram prior to TAVR. Results Of 983 patients who were included in our study, 422 patients (43%) were found to have elevated FP and 561 patients (57%) had normal FP prior to TAVR. Patients with elevated FP had a mean age of 81.2±8.6 years and were more likely to be males (62%), diabetic (41% vs 35%, p=0.046), and have a higher prevalence of atrial fibrillation (Afib) (53% vs 39%, p<0.001). The 5-year all-cause mortality after TAVR was significantly higher in patients with elevated FP when compared with patients with normal FP (32% vs 24%, p=0.006). The presence of elevated FP, history of Afib and prior PCI emerged as independent predictors of long-term mortality after TAVR. Conclusion Elevated FP is associated with increased mortality in patients with severe AS undergoing TAVR. Assessment of FP should be incorporated into the risk assessment of AS patients to identify those who may benefit from early intervention.

1 October 2020 in CASE
Verified
Journal Article
Open access
MCMichael Chetrit
Michael Chetrit
OHOssama Abou Hassan
Ossama Abou Hassan
NHNatalie Ho
Natalie Ho
PCPatrick Collier
Patrick Collier
LRL. Leonardo Rodriguez
L. Leonardo Rodriguez
• CAT is a rare non-neoplastic tumor which may be associated with mobile MAC. • Mobile component carries a high risk of embolization demonstrated in our case series. • Calcified thrombus and CAT may be on a spectrum ranging from acute to chronic.

29 July 2025 in US Cardiology Review
Verified
Journal Article
Open access
PDF file
OHOssama K Abou Hassan
Ossama K Abou Hassan
ECEbere Chukwu
Ebere Chukwu
JSJohn Schmittner
John Schmittner
YKYevgeniy Khariton
Yevgeniy Khariton
MBMadison P Bahe
Madison P Bahe
JHJaime Hernandez-Montfort
Jaime Hernandez-Montfort
Cardiogenic shock (CS) is a severe and life-threatening condition caused by the heart’s inability to provide adequate blood flow, leading to systemic hypoperfusion and multiorgan dysfunction. While acute MI and heart failure with reduced ejection fraction are common causes of CS, restrictive cardiomyopathy (RCM) presents a unique challenge due to its underlying hemodynamic complexities related to myocardial stiffness. RCM is characterized by preserved systolic function but impaired ventricular filling, resulting in elevated diastolic pressures and a tendency for rapid decompensation into shock. This review explores the pathophysiology, diagnostic evaluation, and management of CS in RCM. Diagnostic tools such as echocardiography and hemodynamic monitoring are critical for differentiating the causes of CS. Treatment strategies focus on optimizing volume status, arrhythmia control, and, in some cases, mechanical circulatory support. Heart transplantation remains the definitive treatment for eligible patients. Early recognition and tailored interventions are essential for the enhancement of survival and quality of life in these critically ill patients.